Target Price | $335.56 |
Price | $186.61 |
Potential | 79.82% |
Number of Estimates | 27 |
27 Analysts have issued a price target Atlassian 2026 . The average Atlassian target price is $335.56. This is 79.82% higher than the current stock price. The highest price target is $420.00 125.07% , the lowest is $230.00 23.25% . | |
A rating was issued by 34 analysts: 23 Analysts recommend Atlassian to buy, 11 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Atlassian stock has an average upside potential 2026 of 79.82% . Most analysts recommend the Atlassian stock at Purchase. |
28 Analysts have issued a sales forecast Atlassian 2025 . The average Atlassian sales estimate is $5.2b . This is 8.18% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.3b 9.88% , the lowest is $5.2b 7.53% .
This results in the following potential growth metrics:
2024 | $4.4b | 23.31% |
---|---|---|
2025 | $5.2b | 19.01% |
2026 | $6.2b | 19.82% |
2027 | $7.4b | 19.51% |
2028 | $8.5b | 14.83% |
2029 | $10.0b | 16.89% |
6 Analysts have issued an Atlassian EBITDA forecast 2025. The average Atlassian EBITDA estimate is $1.3b . This is 2,966.52% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $1.3b 3,054.63% , the lowest is $1.2b 2,834.82% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $-26.0m | 89.96% |
---|---|---|
2025 | $1.3b | 5,099.03% |
2026 | $1.6b | 23.95% |
2027 | $2.0b | 25.15% |
2024 | -0.60% | 91.86% |
---|---|---|
2025 | 25.03% | 4,300.84% |
2026 | 25.89% | 3.44% |
2027 | 27.11% | 4.71% |
9 Atlassian Analysts have issued a net profit forecast 2025. The average Atlassian net profit estimate is $-298m . This is 14.60% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $-207m 40.60% , the lowest is $-477m 36.84% .
This results in the following potential growth metrics and future Net Margins:
2024 | $-304m | 38.95% |
---|---|---|
2025 | $-298m | 2.08% |
2026 | $-195m | 34.47% |
2027 | $-26.9m | 86.19% |
2024 | -6.97% | 50.49% |
---|---|---|
2025 | -5.74% | 17.70% |
2026 | -3.14% | 45.30% |
2027 | -0.36% | 88.54% |
9 Analysts have issued a Atlassian forecast for earnings per share. The average Atlassian EPS is $-1.14 . This is 14.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is $-0.79 40.60% , the lowest is $-1.82 36.84% .
This results in the following potential growth metrics and future valuations:
2024 | $-1.16 | 38.95% |
---|---|---|
2025 | $-1.14 | 1.72% |
2026 | $-0.74 | 35.09% |
2027 | $-0.10 | 86.49% |
Current | -140.39 | 6.61% |
---|---|---|
2025 | -164.29 | 17.02% |
2026 | -250.71 | 52.60% |
2027 | -1,815.73 | 624.24% |
Based on analysts' sales estimates for 2025, the Atlassian stock is valued at an EV/Sales of 9.19 and an P/S ratio of 9.43 .
This results in the following potential growth metrics and future valuations:
Current | 9.94 | 23.66% |
---|---|---|
2025 | 9.19 | 7.55% |
2026 | 7.67 | 16.54% |
2027 | 6.42 | 16.33% |
2028 | 5.59 | 12.92% |
2029 | 4.78 | 14.45% |
Current | 10.20 | 22.18% |
---|---|---|
2025 | 9.43 | 7.56% |
2026 | 7.87 | 16.54% |
2027 | 6.58 | 16.33% |
2028 | 5.73 | 12.92% |
2029 | 4.90 | 14.45% |
Analyst | Rating | Action | Date |
---|---|---|---|
Jefferies |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Apr 01 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
Jefferies |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
Stephens & Co. |
➜
Equal-Weight
|
Initiated | Mar 19 2025 |
Macquarie |
Neutral
➜
Neutral
|
Unchanged | Feb 07 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Feb 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Jefferies:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Apr 01 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Mar 31 2025 |
Unchanged
Jefferies:
Buy
➜
Buy
|
Mar 31 2025 |
Initiated
Stephens & Co.:
➜
Equal-Weight
|
Mar 19 2025 |
Unchanged
Macquarie:
Neutral
➜
Neutral
|
Feb 07 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Feb 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.